These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The future of Cochrane Neonatal. Soll RF, Ovelman C, McGuire W. Early Hum Dev; 2020 Nov 04; 150():105191. PubMed ID: 33036834 [Abstract] [Full Text] [Related]
6. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer. Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G. Health Technol Assess; 2001 Nov 04; 5(28):1-110. PubMed ID: 11701100 [Abstract] [Full Text] [Related]
7. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation. Riemsma R, Corro Ramos I, Birnie R, Büyükkaramikli N, Armstrong N, Ryder S, Duffy S, Worthy G, Al M, Severens J, Kleijnen J. Health Technol Assess; 2016 Feb 04; 20(17):v-xxxi, 1-251. PubMed ID: 26933827 [Abstract] [Full Text] [Related]
8. Patnode CD, Evans CV, Senger CA, Redmond N, Lin JS. ; 2017 07 04. PubMed ID: 29364620 [Abstract] [Full Text] [Related]
9. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review. Allen D, Gillen E, Rixson L. JBI Libr Syst Rev; 2009 07 04; 7(3):80-129. PubMed ID: 27820426 [Abstract] [Full Text] [Related]
10. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis. Medical Advisory Secretariat. Ont Health Technol Assess Ser; 2009 07 04; 9(20):1-58. PubMed ID: 23074525 [Abstract] [Full Text] [Related]
11. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL, Figgitt DP. Pharmacoeconomics; 2004 07 04; 22(6):389-411. PubMed ID: 15099124 [Abstract] [Full Text] [Related]
12. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ. Health Technol Assess; 2009 Sep 04; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018 [Abstract] [Full Text] [Related]
13. LeBlanc EL, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA. ; 2018 09 04. PubMed ID: 30354042 [Abstract] [Full Text] [Related]
14. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review. Hennessy EA, Tanner-Smith EE, Finch AJ, Sathe N, Kugley S. Campbell Syst Rev; 2018 09 04; 14(1):1-86. PubMed ID: 37131375 [Abstract] [Full Text] [Related]
15. Behavioural interventions for type 2 diabetes: an evidence-based analysis. Medical Advisory Secretariat. Ont Health Technol Assess Ser; 2009 09 04; 9(21):1-45. PubMed ID: 23074526 [Abstract] [Full Text] [Related]
16. Cost-Effectiveness of the FreeStyle Libre® System Versus Blood Glucose Self-Monitoring in Individuals with Type 2 Diabetes on Insulin Treatment in Sweden. Jendle J, Eeg-Olofsson K, Svensson AM, Franzen S, Lamotte M, Levrat-Guillen F. Diabetes Ther; 2021 Dec 04; 12(12):3137-3152. PubMed ID: 34694584 [Abstract] [Full Text] [Related]
17. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review. Winkley K, Upsher R, Stahl D, Pollard D, Kasera A, Brennan A, Heller S, Ismail K. Health Technol Assess; 2020 Jun 04; 24(28):1-232. PubMed ID: 32568666 [Abstract] [Full Text] [Related]
18. Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings. Tunis SL. Appl Health Econ Health Policy; 2011 Nov 01; 9(6):351-65. PubMed ID: 21892840 [Abstract] [Full Text] [Related]